Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors

SEATTLE, March 12, 2024 -- Atossa Therapeutics, Inc. , a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a...

Related Keywords

New York ,United States ,Tessa Cigler ,Eric Van Zanten ,Weill Cornell ,Globenewswire Inc ,Harvard College ,Weill Cornell Breast Center ,Duke University School Of Medicine ,York Presbyterian Hospital Weill Cornell Medical Center ,Dana Farber Harvard Cancer Center ,Master In Public Health ,Atossa Therapeutics Inc ,Exchange Commission ,Harvard School Of Public Health ,Nasdaq ,Chief Executive ,University School ,Public Health ,Internal Medicine ,Medical Oncology ,Weill Cornell Breast ,Selective Estrogen Receptor Modulator ,Private Securities Litigation Reform Act ,Stock Market ,Annual Reports ,Quarterly Reports ,